Reposted
珠珠海联邦@zbyss
珠海联邦制药股份有限公司。2024年营收约150亿。半合成青霉素、头孢菌素。胰岛素: 重组人胰岛素、甘精胰岛素、门冬胰岛素。原料药+制剂一体化。抗生素产业链。
8:29:13 PM · Jul 9, 2026
147
珠海联邦制药股份有限公司。2024年营收约150亿。半合成青霉素、头孢菌素。胰岛素: 重组人胰岛素、甘精胰岛素、门冬胰岛素。原料药+制剂一体化。抗生素产业链。
Our water system meets USP <1231> chemistry and microbiology specifications.
Tangential flow filtration achieved 10x concentration factor for our mAb process.
Our depot microspheres showed sustained release over 90 days in vivo.
Natural transition orbitals revealed the charge-transfer character of the S1 state.